Your cart is currently empty!
Hypersens™ RT-PCR panels
AI-Optimized Pathogen Detection Designed to Protect Lives
In the pursuit of improving diagnostic testing
Despite advances in detection and treatment, infectious disease remains a major challenge for healthcare providers worldwide. Among the most common infections recorded each year, there are more than 400 million cases of urinary tract infections (UTIs) leading to several hundred thousand deaths, and more than 1 million new cases of sexually transmitted infections (STIs) per day. Of the 11 million deaths from sepsis, 31% start from urinary tract infections.
Minimizing the time from the first symptoms to a correct diagnosis and treatment is critical for saving lives.
We at Medix are dedicated to protecting lives by improving diagnostic testing. That’s why we exist.
Accuracy and efficiency for laboratories with Medix technologies
Currently available methods for detecting infectious disease comprise a complex series of time-consuming, multi-step processes. For example, processing a UTI culture can take more than two days, while the patient might need a prescribed treatment in just a couple of hours. Disappointingly, these methods yield results that are sometimes ambiguous or outright false, hence leading to potentially misdirected treatment options.
We tackle this challenge by combining AI-driven biotechnologies with process innovations that make robust, high-performance pathogen detection available to diagnostic laboratories worldwide.
Our Hypersens™ pathogen detection kits deploy the RT-PCR testing method that is considerably faster than culture testing and offers a comprehensive and more accurate detection of multiple pathogens and antibiotic resistance genes from a single sample.
Hypersens™ kits deliver greater efficiencies to laboratories in terms of higher detection accuracy, customizable panel design, and shorter processing time through multiplexing and an internal control per well. Medix’s RT-PCR panels are the only ones with antibiotic treatment recommendation application.
Hypersens™
Pathogen Detection Technology
✓
Hypersensitive detection
Medix Master Mix is designed for hypersensitive detection of pathogens.
✓
AI-driven design of multiplexed panels
Detection of up to three pathogens or antibiotic-resistance genes per well along with an internal control. Three (3) times faster than singleplexed testing.
✓
Internal control
Built into all Medix test panels. No separate internal control tests needed.
✓
Customizable tests
Laboratories can customize pathogen and/or antibiotic-resistance gene detection on a per-well
granularity and maximize their cost savings within the systems they already use.
✓
Agnostic to testing equipment
Medix panels can be used with RT-PCR equipment without any special calibration.
✓
Targeted antibiotic treatment recommendations
The only RT-PCR panel available with antibiotic treatment software application (U.S. only).
Partnership Programs
Medix Biotechnologies is partnering with diagnostic laboratories, OEMs and ODMs worldwide for research collaboration, co-development, technology licensing, and distribution.
Medix Biotechnologies
Protecting Lives
Contact Us
Medix Biotechnologies Inc.
Headquarters & Production Laboratory
3683 Enochs St
Santa Clara, CA 95051
R&D Laboratory
2627 Hanover St
Palo Alto, CA 94304, USA